The “International Summit on Interventional Pharmacoeconomics” for the first time will bring together leaders and researchers in the fields of pharmacology, health policy and economics, clinical medicine, clinical trials and healthcare management to share knowledge and identify opportunities to lower costs of expensive drugs while maintaining health outcomes in patients.
The opening session will include a keynote address, “Are cancer drug prices in the U.S. the problem or the symptom?” by Clifford Hudis, CEO of ASCO. Subsequent sessions will discuss biosimilars, global policy issues and the use of existing drugs to treat malignant diseases such as multiple myeloma, chronic myelogenous leukemia and infectious diseases such as COVID-19.
To view the program, click here: cpt.uchicago.edu/summit-program-2/
To register for the virtual summit, contact [email protected]
###
About the University of Chicago Medicine & Biological Sciences
The University of Chicago Medicine, with a history dating back to 1927, is one of the nation’s leading academic medical institutions. It unites the missions of the University of Chicago Medical Center, Pritzker School of Medicine and the Biological Sciences Division. Twelve Nobel Prize winners in physiology or medicine have been affiliated with the University of Chicago. Its main Hyde Park campus is home to the Center for Care and Discovery, Bernard Mitchell Hospital, Comer Children’s Hospital and the Duchossois Center for Advanced Medicine. It also has ambulatory facilities in Orland Park and the South Loop as well as affiliations and partnerships that create a regional network of care. UChicago Medicine offers a full range of specialty-care services for adults and children through more than 40 institutes and centers including an NCI-designated Comprehensive Cancer Center.
Original post https://alertarticles.info